Kimberly-Clark to buy Tylenol maker Kenvue in landmark $40bn merger

Kleenex maker’s deal for troubled Johnson & Johnson spinoff comes amid lawsuits and regulatory scrutinyKleenex maker Kimberly-Clark said on Monday it will buy Kenvue for more than $40bn in a landmark deal for the consumer sector, as the Tylenol maker grapples with White House scrutiny and choppy demand.Kimberly-Clark would be scooping up the former Johnson & Johnson unit after months of struggles by Kenvue that include the ouster of its CEO in July and a share slump when Donald Trump in September asserted that Tylenol use can lead to autism, a claim not backed by conclusive research. Continue reading...